Sun Pharma Unveils ESG Overview for FY 2023-24, Reveals 78% Revenue Growth Aug. 27, 2024, 6:04 p.m. <li>Sun Pharmaceutic… Unlock the Full Filing And Lot More Access premium insights and stay ahead of the market with Dzambhala Pro. Learn More